Indivior PLC (LON:INDV – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,238 and traded as low as GBX 1,230. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares.
Indivior Stock Performance
The company has a quick ratio of 1.52, a current ratio of 0.90 and a debt-to-equity ratio of -141.86. The company has a market cap of £1.93 billion, a PE ratio of -1,026.48, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The business has a 50-day simple moving average of GBX 1,238 and a 200-day simple moving average of GBX 1,238.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
Featured Articles
- Five stocks we like better than Indivior
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
- Beyond the AI Trade: 3 Defensive Stocks Built for Stability
- MarketBeat Week in Review – 06/15 – 06/19
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
